Mid-German Sepsis Cohort (MSC): a prospective observational study of sepsis survivorship.
adult intensive & critical care
epidemiology
infectious diseases
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
17 03 2021
17 03 2021
Historique:
entrez:
19
3
2021
pubmed:
20
3
2021
medline:
20
5
2021
Statut:
epublish
Résumé
The Mid-German Sepsis Cohort (MSC) aims to investigate mid-term and long-term functional disabilities in sepsis survivors from intensive care unit (ICU) discharge until 1 year after. Secondary, post-acute mortality and morbidity, health-related quality of life and healthcare utilisation will be investigated. The MSC comprises adult (aged ≥18 years) patients who were treated for (severe) sepsis or septic shock on ICU. The participants were recruited between 15 April 2016 and 30 November 2018 from five German centres. Three thousand two hundred and ten patients with sepsis were identified, of which 1968 survived their ICU stay and were eligible for enrolment in the follow-up cohort. Informed consent for follow-up assessment was provided by 907 patients (46.1% of eligible patients). The recruitment of the participants for follow-up assessments and the baseline data collection is completed. Incidence of sepsis was 116.7 patients per 1000 ICU patients. In this cohort profile, we provide an overview of the demographics and the clinical characteristics of both the overall sepsis cohort and the ICU survivors who provided informed consent for follow-up assessment (907 out of 1968 ICU survivors (46.1%)). The follow-ups are conducted 3, 6 and 12 months after ICU discharge. Another yearly follow-up up to 5 years after ICU discharge is pursued. Several cooperation and satellite projects were initiated. This prospective cohort offers a unique resource for research on long-term sequelae of sepsis survivors. German Clinical Trials Registry (DRKS00010050).
Identifiants
pubmed: 33737430
pii: bmjopen-2020-043352
doi: 10.1136/bmjopen-2020-043352
pmc: PMC7978081
doi:
Banques de données
DRKS
['DRKS00010050']
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e043352Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: CSH declares funding from the German Federal Joint Committee Innovations-Funds and the European Society of Intensive Care Medicine. All other authors declare no conflicts of interest.
Références
PLoS One. 2014 Dec 30;9(12):e116304
pubmed: 25549097
Intensive Care Med. 2007 Apr;33(4):606-18
pubmed: 17323051
N Engl J Med. 2013 Oct 3;369(14):1306-16
pubmed: 24088092
Am J Respir Crit Care Med. 2019 Oct 15;200(8):972-981
pubmed: 31161771
Nat Rev Neurol. 2009 Jul;5(7):372-9
pubmed: 19578344
Lancet Respir Med. 2014 May;2(5):380-6
pubmed: 24740011
BMJ Open. 2017 Aug 23;7(8):e016827
pubmed: 28838900
Lancet Infect Dis. 2017 Nov;17(11):1180-1189
pubmed: 28826588
JAMA. 2010 Oct 27;304(16):1787-94
pubmed: 20978258
J Infect Chemother. 2014 Mar;20(3):157-62
pubmed: 24530102
Anaesthesist. 2010 Apr;59(4):347-70
pubmed: 20414762
Am J Crit Care. 2019 Nov;28(6):424-432
pubmed: 31676516
Nat Rev Immunol. 2013 Dec;13(12):862-74
pubmed: 24232462
Intensive Care Med. 2016 Dec;42(12):1980-1989
pubmed: 27686355
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
BMJ Open. 2018 Apr 4;8(4):e019342
pubmed: 29622574
Crit Care Med. 2018 Sep;46(9):1393-1401
pubmed: 29787415
J Infect Dis. 2020 Jul 21;222(Suppl 2):S74-S83
pubmed: 32691830
Intensive Care Med. 2018 Nov;44(11):1826-1835
pubmed: 30284637
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Crit Care Med. 2013 Jan;41(1):69-75
pubmed: 23222259
Mol Neurobiol. 2019 Jan;56(1):186-251
pubmed: 29687346
BMJ Open. 2020 Jun 23;10(6):e036527
pubmed: 32580988
Crit Care. 2009;13(3):R103
pubmed: 19566927
Aust Crit Care. 2018 Jul;31(4):204-211
pubmed: 28736089
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
J Crit Care. 2019 Oct;53:149-154
pubmed: 31247513